Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Characterization of TDP-43 Inclusions in Frontotemporal Degeneration

FY 2017-18

Summary
Frontotemporal degeneration (FTD) is a progressive neurodegenerative disease with variable symptoms that can make it difficult to differentiate from Alzheimer's disease. This can lead to misdiagnosis and treatments that may be ineffective or harmful in FTD. In order to properly diagnose FTD, tests are needed that can distinguish FTD from related disorders such as Alzheimer's disease. This study aims to better our understanding of FTD and identify disease-specific markers that could be used to generate new biofluid tests for FTD. This will be achieved by detailed characterization of the affected brain tissue from individuals with FTD, compared to those without the disease. With this first report of the detailed composition of diseased areas of the brain, we will identify signatures of FTD that could be used to identify the disease in a living individual. The outcomes of this study could lead a better understanding of FTD progression, and open up new areas of research for FTD.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
386559
Name
Forgrave Lauren M
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of TDP-43 Inclusions in Frontotemporal Degeneration
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Biomarker; Dementia; Diagnostic Method; Frontotemporal Degeneration; Mass Spectrometry; Neurodegeneration; Neuropathology; Post-Translational Modifications; Tdp-43
Abstract
Frontotemporal degeneration (FTD) is a progressive neurodegenerative disease with variable symptoms that can make it difficult to differentiate from Alzheimer's disease. This can lead to misdiagnosis and treatments that may be ineffective or harmful in FTD. In order to properly diagnose FTD, tests are needed that can distinguish FTD from related disorders such as Alzheimer's disease. This study aims to better our understanding of FTD and identify disease-specific markers that could be used to generate new biofluid tests for FTD. This will be achieved by detailed characterization of the affected brain tissue from individuals with FTD, compared to those without the disease. With this first report of the detailed composition of diseased areas of the brain, we will identify signatures of FTD that could be used to identify the disease in a living individual. The outcomes of this study could lead a better understanding of FTD progression, and open up new areas of research for FTD.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Forgrave, Lauren M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~